Millennium Management’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,817
| Closed | -$14.9K | – | 6351 |
|
|
2025
Q4 | $14.9K | Sell |
10,817
-372,902
| -97% | -$780K | ﹤0.01% | 5838 |
|
|
2025
Q3 | $1.05M | Sell |
383,719
-494,400
| -56% | -$1.76M | ﹤0.01% | 4595 |
|
|
2025
Q2 | $3.06M | Buy |
878,119
+220,394
| +34% | +$870K | ﹤0.01% | 3479 |
|
|
2025
Q1 | $2.42M | Buy |
+657,725
| New | +$2.4M | ﹤0.01% | 3604 |
|
|
2024
Q3 | – | Sell |
-59,058
| Closed | -$106K | – | 6460 |
|
|
2024
Q2 | $106K | Sell |
59,058
-7,648
| -11% | -$22.1K | ﹤0.01% | 5301 |
|
|
2024
Q1 | $318K | Buy |
+66,706
| New | +$234K | ﹤0.01% | 5100 |
|
|
2023
Q3 | – | Sell |
-238,732
| Closed | -$513K | – | 6538 |
|
|
2023
Q2 | $513K | Sell |
238,732
-70,679
| -23% | -$171K | ﹤0.01% | 4522 |
|
|
2023
Q1 | $900K | Buy |
309,411
+76,227
| +33% | +$384K | ﹤0.01% | 4186 |
|
|
2022
Q4 | $1.6M | Sell |
233,184
-42,834
| -16% | -$202K | ﹤0.01% | 3750 |
|
|
2022
Q3 | $878K | Sell |
276,018
-283,413
| -51% | -$1.03M | ﹤0.01% | 4449 |
|
|
2022
Q2 | $1.8M | Sell |
559,431
-191,122
| -25% | -$555K | ﹤0.01% | 3817 |
|
|
2022
Q1 | $2.27M | Buy |
750,553
+317,444
| +73% | +$1.07M | ﹤0.01% | 3758 |
|
|
2021
Q4 | $1.93M | Buy |
433,109
+329,752
| +319% | +$1.61M | ﹤0.01% | 3812 |
|
|
2021
Q3 | $678K | Buy |
103,357
+39,875
| +63% | +$382K | ﹤0.01% | 5052 |
|
|
2021
Q2 | $1.02M | Sell |
63,482
-251,437
| -80% | -$3.47M | ﹤0.01% | 4649 |
|
|
2021
Q1 | $3.9M | Buy |
314,919
+244,173
| +345% | +$3.74M | ﹤0.01% | 2855 |
|
|
2020
Q4 | $786K | Buy |
+70,746
| New | +$532K | ﹤0.01% | 3884 |
|
|
2020
Q3 | – | Sell |
-12,710
| Closed | -$25K | – | 4808 |
|
|
2020
Q2 | $25K | Buy |
+12,710
| New | +$26.1K | ﹤0.01% | 4085 |
|
|
2020
Q1 | – | Sell |
-49,445
| Closed | -$222K | – | 4446 |
|
|
2019
Q4 | $222K | Buy |
49,445
+13,637
| +38% | +$84.7K | ﹤0.01% | 3824 |
|
|
2019
Q3 | $297K | Sell |
35,808
-30,517
| -46% | -$333K | ﹤0.01% | 3577 |
|
|
2019
Q2 | $830K | Buy |
+66,325
| New | +$937K | ﹤0.01% | 2915 |
|
|
2019
Q1 | – | Sell |
-15,679
| Closed | -$303K | – | 4315 |
|
|
2018
Q4 | $303K | Buy |
+15,679
| New | +$344K | ﹤0.01% | 3212 |
|
|
2018
Q3 | – | Sell |
-44,965
| Closed | -$1.2M | – | 4257 |
|
|
2018
Q2 | $1.2M | Buy |
+44,965
| New | +$1.22M | ﹤0.01% | 2725 |
|
Other funds holding STIM
MAM
VCM
LG
FCM
MCM
Millennium Management's STIM Position: Q1 2026 in Review
Millennium Management sold out of Neuronetics (STIM) in Q1 2026, closing a stake of 10,817 shares — an estimated $14.9K sold.
Millennium Management first reported a position in STIM in Q2 2018 and held it in 23 quarters. The position peaked at $3.9M in Q1 2021. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.
- Millennium Management reported no remaining Neuronetics position as of Q1 2026 after selling out during the quarter.
- Millennium Management sold 10,817 Neuronetics shares in Q1 2026, an estimated $14.9K.
- Millennium Management first reported a position in Neuronetics in Q2 2018 and held it in 23 quarters.
- Millennium Management's Neuronetics position peaked at $3.9M in Q1 2021.
- 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.